[Correlation between C-reactive protein levels with leading risk factors for cardiovascular disease in men]

Bosa Mirjanić-Azarić1, Mirjana Derić, Maja Vrhovac

  • 1Dom zdravlja "Banja Luka", Banja Luka, Republika Srpska. laboratorija.dz@blic.net

Medicinski Pregled
|September 9, 2008
PubMed

Insights

High sensitive C-reactive protein (CRP) correlates with high blood pressure and increased body mass index in men. CRP screening aids in early cardiovascular disease detection and prevention.

Area of Science:

  • Biochemistry
  • Cardiovascular Medicine
  • Public Health

Context:

  • Cardiovascular disease (CVD) risk factors are prevalent in the male population.
  • Inflammation, indicated by C-reactive protein (CRP), is increasingly recognized as a key player in CVD pathogenesis.
  • Understanding the relationship between CRP and traditional CVD risk factors is crucial for effective prevention strategies.

Purpose:

  • To investigate the correlation between high-sensitive C-reactive protein (hs-CRP) levels and major cardiovascular disease risk factors in a cohort of working men.
  • To determine if hs-CRP levels differ significantly based on blood pressure and body mass index categories.

Summary:

  • This study analyzed hs-CRP levels in 183 men, alongside measurements of blood pressure, body mass index, and lipid profiles.
  • Results indicated a statistically significant correlation between elevated hs-CRP levels and both diastolic blood pressure above 90 mmHg and increased body mass index (BMI).
  • No significant correlation was found between hs-CRP levels and total cholesterol, HDL-cholesterol, or LDL-cholesterol.

Impact:

  • The findings highlight the utility of hs-CRP as a potential biomarker for identifying men at higher risk of cardiovascular disease, particularly those with hypertension and obesity.
  • hs-CRP screening can aid in the early detection and prevention of cardiovascular diseases.
  • These results support the integration of hs-CRP testing into routine health check-ups for proactive cardiovascular risk assessment in men.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...